Atlas-backed biotech startup emerges with $25M and a plan to perfect gene therapy

Gene therapies — drugs that work by inserting healthy genes into a person’s cells to augment faulty ones — have generated significant buzz in recent years because of their potential to permanently cure a wide range of diseases. But the approach has some limitations. The viruses that are typically used to del iver the genes can trigger harmful immune responses in some patients. Even if that doesn't happen, the drugs can’t be re-dosed if and when the effects start to wear off. Generation Bio,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news